BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16638187)

  • 41. Coexistence of tetrasomy 8 and trisomy 8 in acute promyelocytic leukemia (AML-M3) with t(15;17)(q22;q12).
    Wang HP; Li GX; Qiao ZH; Ren WY; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):406-10. PubMed ID: 15363120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
    La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
    Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
    Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
    Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
    Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
    von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
    Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
    Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
    Slovak ML; Gundacker H; Bloomfield CD; Dewald G; Appelbaum FR; Larson RA; Tallman MS; Bennett JM; Stirewalt DL; Meshinchi S; Willman CL; Ravindranath Y; Alonzo TA; Carroll AJ; Raimondi SC; Heerema NA
    Leukemia; 2006 Jul; 20(7):1295-7. PubMed ID: 16628187
    [No Abstract]   [Full Text] [Related]  

  • 48. Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis.
    Ishiyama K; Takami A; Kanda Y; Nakao S; Hidaka M; Maeda T; Naoe T; Taniguchi S; Kawa K; Nagamura T; Atsuta Y; Sakamaki H
    Leukemia; 2012 Mar; 26(3):461-4. PubMed ID: 21869835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
    Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
    Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Giant cellulitis-like Sweet syndrome as an initial clinical presentation of acute myeloblastic leukemia with t(6;9)(p23;q34): DEK-CAN and internal duplications of FMS-like tyrosine kinase 3.
    Okuyama S; Nito T; Yanagawa N; Tajima K
    Ann Hematol; 2019 Mar; 98(3):787-788. PubMed ID: 30659317
    [No Abstract]   [Full Text] [Related]  

  • 51. [Combined application of multiplex reverse transcription-polymerase chain reaction and karyotype analysis to detection of clonal chromosomal aberrations in acute myeloid leukemia].
    Huang L; Li CR; Zhang H; Sun LS; Liu WL; Zhou JF
    Ai Zheng; 2007 Sep; 26(9):1029-33. PubMed ID: 17927867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
    Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
    Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.
    Boer J; Mahmoud H; Raimondi S; Grosveld G; Krance R
    Leukemia; 1997 Feb; 11(2):299-300. PubMed ID: 9009096
    [No Abstract]   [Full Text] [Related]  

  • 55. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
    Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
    Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.
    Abildgaard L; Ommen HB; Lausen B; Hasle H; Nyvold CG
    Eur J Haematol; 2013 Nov; 91(5):394-8. PubMed ID: 23772754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
    Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
    Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fluorescence in situ hybridization studies on a myeloid leukemia patient with ins(8;21)(q22;q22.1q22.3)].
    Wu YF; Xue YQ; Bai SX; Zhang J; Yao L; Wang Y; Qiu HY; Shen J; Pan JL; Ma QF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):203-6. PubMed ID: 19350517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.